Instrument Inactif

Autres langues IMARA

Actions

IMRA

US45249V1070

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Enliven Therapeutics Completes Merger With Imara	24/02/23
IMARA Inc.(NasdaqGS:IMRA) dropped from NASDAQ Composite Index	23/02/23
Enliven Therapeutics, Inc. completed the acquisition of IMARA Inc. from a group of shareholders for approximately $340 million in a reverse merger transaction.	23/02/23
IMARA INC. : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	22/02/23
Imara Announces Stockholder Approval of Merger With Enliven	22/02/23
Imara Announces Stockholder Approval of Merger With Enliven	22/02/23
IMARA INC. : Other Events (form 8-K)	13/02/23
IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	10/02/23
IMARA Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10/02/23
IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA	25/01/23
Top Premarket Decliners	09/01/23
IMARA INC. : Other Events (form 8-K)	05/12/22
IMARA INC. Financial Statements and Exhibits (form 8-K/A)	16/11/22
IMARA INC. : Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	10/11/22
Cardurion Pharmaceuticals, LLC acquired Tovinontrine (IMR-687) and All of the Assets Related to PDE9 Program from IMARA Inc. for approximately $95.	10/11/22
IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	25/10/22
IMARA Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/10/22
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of IMARA Inc. - IMRA	19/10/22
IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA	15/10/22
SHAREHOLDER ALERT: Weiss Law Investigates IMARA Inc.	14/10/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues IMARA

Actions

IMRA

US45249V1070

Autres langues

Filtres